Fungal dysbiosis in cirrhtic patients due to the use of antimicrobials. Risk or benefit
Abstract
Lina Marcela Ortiz Roncallo, Carlos Andres Perez Lozano, Adalberto Ruiz Ballesta, Silvia Juliana Rodriguez Perez, Amaury Gustavo Lopez Agamez, Maria Jose Alvarez Gomez, Ricardo Javier Galvan Zuniga, Carlos Mauricio Castro Gonzalez
There is a significantly marked fungal dysbiosis in cirrhotic patients, which changes differentially with the use of antibiotics and proton pump inhibitors, although it is known that patients with cirrhosis have a fairly weakened immune system, therefore, these have a greater risk of developing bacterial infections, the use in this type of patients of drugs such as proton pump inhibitors and antimicrobials, represents an even greater risk of developing, no longer bacterial infections, but of fungal origin [1].